{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:39:00Z","timestamp":1789439940221,"version":"build-2803163510"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Studies have not yet found conclusive results on the risk of cancer in patients with multiple sclerosis (MS). This study aimed to compare the incidence of all cancers and of specific types of cancer between MS patients and the general population by age and by sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All prevalent MS patients identified between 2008 and 2014 in the nationwide French health care database (Syst\u00e8me National des Donn\u00e9es de Sant\u00e9) and without history of malignancy were included in a cohort study and followed up until cancer occurrence, date of death, or 31 December 2015, whichever came first. MS patients were matched based on sex and year of birth to non\u2010MS controls from the general population without cancer before index date. Incidence rate was reported per 100,000 person\u2010years (PY), and risk of cancer was estimated by type of cancer, age, and sex using a Cox model (hazard ratio [HR] and its 95% confidence interval [CI]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 576 cancers per 100,000 PY were observed in MS patients versus 424 per 100,000 PY in the control population. The risk of cancer was higher among MS patients than among population controls whether considered overall (HR = 1.36, 95% CI = 1.29\u20131.43) or for prostate (HR = 2.08, 95% CI = 1.68\u20132.58), colorectal and anal (HR = 1.35, 95% CI = 1.16\u20131.58), trachea, bronchus, and lung (HR = 2.36, 95% CI = 1.96\u20132.84), and to a lesser extent, breast cancer (HR = 1.12, 95% CI = 1.03\u20131.23).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MS patients were associated with increased risk of cancer compared to population controls.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ene.15226","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T09:17:57Z","timestamp":1640164677000},"page":"1091-1099","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Incidence and risk of cancer among multiple sclerosis patients: A matched population\u2010based cohort study"],"prefix":"10.1111","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9763-5974","authenticated-orcid":false,"given":"Pauline","family":"Bosco\u2010L\u00e9vy","sequence":"first","affiliation":[{"name":"Bordeaux PharmacoEpi University of Bordeaux National Institute of Health and Medical Research CIC\u2010P1401 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Foch","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Merck Healthcare Darmstadt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Grelaud","sequence":"additional","affiliation":[{"name":"Bordeaux PharmacoEpi University of Bordeaux National Institute of Health and Medical Research CIC\u2010P1401 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Sabid\u00f3","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Merck Healthcare Darmstadt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Lacueille","sequence":"additional","affiliation":[{"name":"Bordeaux PharmacoEpi University of Bordeaux National Institute of Health and Medical Research CIC\u2010P1401 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Jov\u00e9","sequence":"additional","affiliation":[{"name":"Bordeaux PharmacoEpi University of Bordeaux National Institute of Health and Medical Research CIC\u2010P1401 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Boutmy","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Merck Healthcare Darmstadt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4005-7928","authenticated-orcid":false,"given":"Patrick","family":"Blin","sequence":"additional","affiliation":[{"name":"Bordeaux PharmacoEpi University of Bordeaux National Institute of Health and Medical Research CIC\u2010P1401 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100047351"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020482"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04143.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200839073"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-018-0004-4"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102650"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514564489"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2017.05.004"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4233"},{"issue":"42","key":"e_1_2_9_11_1","first-page":"6","article-title":"Certification des comptes: Une incitation \u00e0 la tra\u00e7abilit\u00e9 des processus de contr\u00f4le","volume":"582","author":"Gilleron V","year":"2018","journal-title":"Revue Hospitaliere de France"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2010.04.005"},{"key":"e_1_2_9_13_1","unstructured":"M\u00e9thodologie g\u00e9n\u00e9rale de la cartographie des pathologies d\u00e9velopp\u00e9e par la CnamTS pour les ann\u00e9es 2012\u20102013\u20102014[Internet]. Caisse Nationale d\u2019Assurance Maladie (CNAM);2016juill [cit\u00e9 19 oct 2017] p.6\u20137. Disponible sur:https:\/\/www.ameli.fr\/fileadmin\/user_upload\/documents\/Cartographie_des_pathologies__methodologie_detaillee.pdf"},{"key":"e_1_2_9_14_1","unstructured":"DefossezG Le Guyader\u2010Peyrou S UhryZ et al.Estimations nationales incidence et mortalite par cancer[Internet]. Paris France: Institut National du Cancer; 2019 juill [cit\u00e9 17 f\u00e9vr 2021]. Disponible sur:https:\/\/www.e\u2010cancer.fr\/Expertises\u2010et\u2010publications\/Catalogue\u2010des\u2010publications\/Synthese\u2010Estimations\u2010nationales\u2010de\u2010l\u2010incidence\u2010et\u2010de\u2010la\u2010mortalite\u2010par\u2010cancer\u2010en\u2010France\u2010metropolitaine\u2010entre\u20101990\u2010et\u201020182"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1991.tb04941.x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12267"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519877244"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.12.014"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1996.tb00019.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21437"},{"issue":"3","key":"e_1_2_9_21_1","first-page":"172","article-title":"Cancer risk among patients with multiple sclerosis: a cohort study in Isfahan, Iran","volume":"8","author":"Etemadifar M","year":"2017","journal-title":"Casp J Intern Med"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.08.005"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000079947"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458507083625"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-2229-4"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000356498"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2016.10.008"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000345366.10455.62"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws148"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.07.020"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519851245"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-006-0676-x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006384"},{"issue":"4","key":"e_1_2_9_34_1","first-page":"248","article-title":"High incidence of hyperandrogenism\u2010related clinical signs in patients with multiple sclerosis","volume":"22","author":"Falaschi P","year":"2001","journal-title":"Neuro Endocrinol Lett"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4036232"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i31.4199"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.175463"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8513-0"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.15226","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ene.15226","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.15226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T18:56:27Z","timestamp":1692989787000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.15226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1111\/ene.15226"],"URL":"https:\/\/doi.org\/10.1111\/ene.15226","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"2021-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}